Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Keita Sakamoto and Yutaka Muto.
Keita Sakamoto
Connection Strength
0.120
Yutaka Muto
  1. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19. Respir Investig. 2021 Nov; 59(6):799-803.
    View in: PubMed
    Score: 0.060
  2. Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan. Respir Investig. 2021 Sep; 59(5):635-642.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.